研究人员提出了评估药品价值的新方法,旨在提供更廉价的治疗方法。 Researchers propose new method to assess medicine value, aiming for more affordable treatments.

十二名主要卫生经济学家发表了一份文件,提出了一种称为普遍成本效益分析的新方法,以便更好地评估药物的价值。 Twelve leading health economists have published a paper proposing a new method called generalized cost-effectiveness analysis (GCEA) to better assess the value of medicines. 这一办法旨在通过考虑经常被忽视的15个附加价值要素,解决常规成本效益分析中的缺陷。 This approach aims to address shortcomings in conventional cost-effectiveness analysis by considering 15 additional elements of value that are often overlooked. 提交人辩称,这可能导致为病人提供更负担得起和更易获得的治疗。 The authors argue that this could lead to more affordable and accessible treatments for patients.